Patient#	Sample#	HPV-16 E6/E6AP/NFX1/SIN3/HDAC complex:(HPV-16 E6/E6AP, active),(NFX1/SIN3/HDAC complex, active),	KU/TER:(KU, active),(TER, active),	ubiquitin-dependent protein catabolic process:(HPV-16 E6/E6AP/NFX1/SIN3/HDAC complex, active),	ABL1:(ABL1, protein),	ACD:(ACD, protein),	Apollo:(Apollo, protein),	BLM:(BLM, protein),	CDKN1B:(CDKN1B, protein),	DKC1:(DKC1, protein),	E2F1:(E2F1, protein),	ERK1-2:(ERK1-2, protein),	ESR1:(ESR1, protein),	FRAP1:(FRAP1, protein),	HSP90AA1:(HSP90AA1, protein),	IFNAR2:(IFNAR2, protein),	IL2:(IL2, protein),	HNRNPC:(HNRNPC, protein),	MYC:(MYC, protein),	NCL:(NCL, protein),	NFKB1:(NFKB1, protein),	PARP2:(PARP2, protein),	PIF1:(PIF1, protein),	NR2F2:(NR2F2, protein),	PINX1:(PINX1, protein),	PKC isoenzymes:(PKC isoenzymes, protein),	POT1:(POT1, protein),	RPS6KB1:(RPS6KB1, protein),	SMAD3:(SMAD3, protein),(TGFB1/TGF beta receptor Type II, active),	PTGES3:(PTGES3, protein),	SMG5:(SMG5, protein),	SP1:(SP1, protein),	TERF2:(TERF2, protein),	TERF2IP:(TERF2IP, protein),	TERT isoform 2:(TERT isoform 2, protein),	TINF2:(TINF2, protein),	TRF1:(TRF1, protein),	Tankyrase1:(Tankyrase1, protein),	WRN:(WRN, protein),	WT1:(WT1, protein),	YWHAE:(YWHAE, protein),	ER alpha/Oestrogen:(ESR1, active),(Oestrogen, active),	ERK1-2-active:(ERK1-2, active),(ERK1-2-active, protein),(IL2, active),	MRN complex/TRF2/Rap1:(MRN complex, active),(TERF2, active),(TERF2IP, active),	SMG6:(SMG6, protein),	Smad3/MYC:(MYC, active),(SMAD3, active),	TRF1 dimer:(TRF1, active),	TRF1/Tankyrase1:(TRF1, active),(Tankyrase1, active),	TRF2/BLM:(BLM, active),(TERF2, active),	TRF2/PARP2:(PARP2, active),(TERF2, active),	AKT1:(AKT1, protein),(ER alpha/Oestrogen, active),(IL2, active),	Shelterin Complex:(ACD, active),(POT1, active),(TERF2, active),(TERF2IP, active),(TINF2, active),(TRF1, active),	TRF2/WRN:(TERF2, active),(WRN, active),	cell cycle:(ERK1-2-active, active),	positive regulation of telomere maintenance:(TRF1/Tankyrase1, active),	regulation of telomere maintenance:(TRF1 dimer, active),(telomeric DNA binding, active),	Shelterin Complex/Apollo:(Apollo, active),(Shelterin Complex, active),	TERT:(TERT, protein),	KU/TERT:(KU, active),(TERT, active),	TERT/NF kappa B1/14-3-3:(AKT1, active),(NFKB1, active),(TERT, active),(YWHAE, active),	Telomerase catalytic core complex:(TER, active),(TERT, active),	TERT/c-Abl:(ABL1, active),(TERT, active),(response to DNA damage stimulus, active),	CCND1:(CCND1, protein),	Telomerase:(CDKN1B, active),(DKC1, active),(HPV-16 E6/E6AP, active),(HSP90AA1, active),(IFN-gamma/IRF1, active),(PIF1, active),(PKC isoenzymes, active),(PTGES3, active),(TER, active),(TERT isoform 2, active),(Telomerase catalytic core complex, active),(telomeric DNA binding, active),	Telomerase/911:(911 complex, active),(Telomerase, active),	Telomerase/EST1A:(SMG6, active),(Telomerase, active),	Telomerase/EST1B:(SMG5, active),(Telomerase, active),	Telomerase/Nucleolin:(NCL, active),(Telomerase, active),	Telomerase/PinX1:(PINX1, active),(Telomerase, active),	Telomerase/hnRNP C1/C2:(HNRNPC, active),(Telomerase, active),	Telomerase/AKT1/mTOR/p70S6K:(AKT1, active),(FRAP1, active),(IL2, active),(RPS6KB1, active),(Telomerase, active),	ATM	ATM/TRF2:(ATM, active),(TERF2, active),	DNA damage response signal transduction by p53 class mediator resulting in induction of apoptosis:(ATM, active),(telomeric DNA binding, active),	
